Cargando…
NOD2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination
We describe a patient who developed multiple granulomatous skin lesions after Bacille de Calmette et Guérin (BCG) vaccination without significant effect by topical corticosteroid, followed by painless cystic tumors on the bilateral knees and hands and inflammatory changes on ophthalmologic examinati...
Autores principales: | Arakawa, Akiko, Kambe, Naotomo, Nishikomori, Ryuta, Tanabe, Akiyo, Ueda, Masamichi, Nishigori, Chikako, Miyachi, Yoshiki, Kanazawa, Nobuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915141/ https://www.ncbi.nlm.nih.gov/pubmed/33562038 http://dx.doi.org/10.3390/children8020117 |
Ejemplares similares
-
Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis
por: Matsuda, Tomoko, et al.
Publicado: (2022) -
Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome
por: Ikeda, Kei, et al.
Publicado: (2014) -
Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome
por: Chang, Shao-Yu, et al.
Publicado: (2022) -
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
por: Ueki, Yoko, et al.
Publicado: (2023) -
Sustained Surface ICAM-1 Expression and Transient PDGF-B Production by Phorbol Myristate Acetate-Activated THP-1 Cells Harboring Blau Syndrome-Associated NOD2 Mutations
por: Nishiyama, Mizuho, et al.
Publicado: (2021)